<DOC>
	<DOC>NCT01212601</DOC>
	<brief_summary>This is a Multicenter, observational, non-interventional registry designed to collect clinical data in Chinese patients who have received CUBICIN treatment under condition of actual usage in clinical practice.</brief_summary>
	<brief_title>Collect Clinical Data in Chinese Patients Received CUBICIN Treatment for Actual Usage in Clinical Practice</brief_title>
	<detailed_description>MC MD</detailed_description>
	<mesh_term>Daptomycin</mesh_term>
	<criteria>Patient has received CUBICIN treatment, decided by treating physician A patient who is considered as ethnic Chinese Provision of subject informed consent A patient record will not be eligible for the registry database if the patient received CUBICIN as part of a controlled clinical study for the current infection episode.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>safety</keyword>
	<keyword>efficacy</keyword>
	<keyword>Chinese patients</keyword>
	<keyword>practice</keyword>
</DOC>